Central Arousal Neuroscience

The pathway
others overlooked.

Paradoxica advances a peer-reviewed mechanism of central sexual excitation: a route around SSRI-induced sexual dysfunction that operates independently of serotonergic suppression.

Published Research
SIGNAL · CENTRAL AROUSAL PATHWAY
STATE · EXCITATION PATHWAY · NON-SEROTONERGIC
Primary Publication
Sexual Medicine
Oxford University Press
Mechanism
Proprietary ·
Characterized
Lead Indication
SSRI-Associated
Dysfunction
Intellectual Property
Provisional
Filed
The Discovery

A mechanism hiding
in plain sight.

Paradoxica's foundational research identifies a route to central sexual arousal that operates independently of serotonergic suppression, the system that conventional antidepressants disrupt. The observation is published and peer-reviewed. The mechanism is proprietary.

Sexual Medicine · Oxford University Press · ISSM

Peer-reviewed. On the scientific record.

“From sedation to stimulation: anecdotal case reports of enhanced sexual arousal in men and women taking diphenhydramine hydrochloride.”

Regis & Pfaus · Vol 14, Issue 2 · March 2026 · DOI 10.1093/sexmed/qfag011

Read the full study at Oxford University Press →
Accepted following independent peer review
Co-authored with an internationally recognized sexual neuropharmacologist
Establishes the basis for controlled clinical validation
Pharmacological Logic

The mechanism is
characterized.

Paradoxica's working model traces how the pathway resolves, from serotonergic inhibition, through an enzymatic conversion, to restored central response. The full mechanistic detail, responder hypothesis, and metabolic profiling are held in the research dossier.

Stage 01

The inhibited state

Why conventional serotonergic treatment suppresses central arousal, and why existing interventions fail to restore it.

Stage 02 · Restricted

The conversion · in dossier

The proprietary mechanistic step. Available to verified institutional partners under confidentiality.

Stage 03

Restored central response

Sensory and orgasmic function re-established through a route independent of serotonergic state.

The Platform

A system for finding
what others miss.

SSRI-associated dysfunction is the first indication, not the thesis. Paradoxica is built around a repeatable method: surface overlooked therapeutic signals, characterize the responders and mechanisms behind them, and develop the compounds that reproduce them. One pathway proven becomes a platform for many.

Surface
Identify overlooked therapeutic signals
Characterize
Responder populations & mechanisms
Develop
Compounds that reproduce the effect

Lead program: central arousal restoration. Pipeline: a class of sensory-restoration indications sharing the same discovery engine.

Institutional Access

Request the
research dossier.

Scientific collaborators and institutional partners may request Paradoxica's research dossier and development outline following professional verification and a confidentiality acknowledgement.